Consider the source.
Understand the evidence.
Thoughtful formulation starts with good questions. Clear information explains what an ingredient is—and what the evidence can actually tell us.
Before our first launch. Our first product is in development. This page explains our approach and current project status; it is not a clinical study of the finished ALTIOMA formula.
Good science has context.
What was studied?
A nutrient, an ingredient form and a finished formula are different subjects. Evidence for one does not automatically establish an outcome for another.
How was it studied?
Study design, participants, amount, duration and measured outcomes affect how findings should be interpreted. A plausible mechanism is a starting point, not proof of a benefit.
What does it show?
Quality testing and clinical research answer different questions. A test of identity or composition cannot by itself demonstrate improved sleep, recovery or another health outcome.
Ask better questions.
Make clearer distinctions.
Our approach begins with a defined ingredient source and a formulation brief. The next questions concern composition, serving information, manufacturing requirements and the documents needed to explain the finished product accurately.
Scientific imagery can express curiosity. Evidence must still come from the relevant research and verified documents, with their scope and limitations clearly stated.
Explore our development standards ↗
Four steps.
A clearer picture.
Select a stage to see its purpose and where our project stands.
Start with a defined ingredient.
Our first formulation is being developed with Albion® TRAACS® magnesium bisglycinate chelate from Balchem. Our development requirement is fully chelated, non-buffered magnesium, with no magnesium oxide.
Supplier identity and ingredient specifications explain what the raw material is. They do not establish that the finished ALTIOMA product has been manufactured or clinically tested.
Make the serving information clear.
The bottle count is approved at 180 capsules. Our current plan is a serving of three vegan capsules, targeting approximately 200 mg elemental magnesium and approximately 60 servings per bottle.
The approved label will confirm ingredient amounts, other ingredients, capsule materials, warnings and directions. These targets are not personal dosage advice.
Verify before presenting results.
S.K. Labs is our selected U.S. manufacturing partner. Applicable quality and testing documents will be identified when available and verified. Finished-product reports are not published on this page.
A batch Certificate of Analysis or laboratory report concerns a particular scope of testing. It is different from an independent certification and does not demonstrate a clinical benefit.
Publish the complete picture.
Our first product remains in development and is not currently available for purchase. Final product information, availability and purchase conditions will be published when confirmed.
A packaging concept, a wholesale approval or an ingredient trademark does not mean the product has launched. No launch date is confirmed.
This is an explanation of development stages, not a measured progress score or a promise of completion dates.
Albion® TRAACS®
from Balchem.
We have selected a defined magnesium ingredient source for our first formulation. Balchem describes TRAACS®—The Real Amino Acid Chelate System—as its designation for fully reacted ingredients meeting its chelation-verification standards.
That supplier designation concerns the ingredient. It does not certify a finished ALTIOMA product or guarantee an individual result.
Read about Albion® Minerals at Balchem ↗Magnesium has
everyday roles.
The NIH Office of Dietary Supplements describes magnesium’s involvement in muscle and nerve function and in processes that build proteins, bones and DNA. These general roles explain why magnesium is an essential nutrient.
They do not establish that the developing ALTIOMA formula treats a condition or delivers a particular result. Food intake, individual needs and medical circumstances matter.
Explore the NIH magnesium fact sheet ↗Two questions.
Different answers.
Quality review: Does the tested sample meet the specifications examined?
Clinical research: What happened to measured outcomes under the conditions studied?
One is not a substitute for the other.
A little more clarity.
Does chelation prove a clinical benefit?
No. Chelation describes an ingredient structure. Any claim about the finished product requires evidence appropriate to that claim, including its context and limitations.
Is a COA the same as certification?
No. A batch Certificate of Analysis or laboratory report documents specified results for its stated sample or scope. It should not be presented as an unrelated third-party certification or proof of a health outcome.
Has the finished ALTIOMA formula been clinically tested?
No finished-formula clinical study is presented or claimed on this page. Supplier research and general magnesium information are separate from a clinical evaluation of our developing product.
Can this page tell me what dose to take?
No. The planned serving describes a development specification. Discuss suitability with a qualified healthcare professional, particularly if you take medication, have a medical condition, are pregnant or nursing, or are considering use by a child.
See the ingredient details.
Visit Ingredients, our FAQ and Disclaimer for current product-development information.
Ask us about the evidence.
Questions about an ingredient, a document or a statement? Contact our team.
Contact us ↗